Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutational alterations of the p16CDKN2A tumor suppressor gene have low incidence in mesenchymal chondrosarcoma.

Oncology research - 1 Jan 2000

Bae D K, Park Y K, Chi S G, Lee C W, Unni K K

Abstract excerpt

Mutational inactivation of the cyclin-dependent kinase inhibitors (CDKIs) (p16INK4A/MTS1) tumor suppressor gene has been found in a variety of human tumor types. To investigate the involvement of CDKI abnormality in mesenchymal chondrosarcoma, alterations of CDKIs were examined in human mesenchymal chondrosarcoma tissues using a quantitative DNA/PCR, PCR-SSCP. Seven of 33 specimens (21.2%) showed abnormally low...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Neoplasms
Share to Cyclin-Dependent Kinase Inhibitor p16

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to DNA Mutational Analysis

Share to DNA Primers

Share to Electrophoresis, Polyacrylamide Gel

Share to Genes, p16

Share to Polymorphism, Single-Stranded Conformational

Source

Identifiers

PMID: 11061340
DOI: 10.3727/000000001108747381

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutational alterations of the p16CDKN2A tumor suppressor gene have low incidence in mesenchymal chondrosarcoma.PMID 11061340Read ↗

Low incidence of genetic alterations of the p16CDKN2a in clear cell chondrosarcoma.Semantic proximity Read ↗

Mutational alteration of the p16CDKN2a tumor suppressor gene is infrequent in Ewing's sarcoma.Semantic proximity Read ↗

Gene alterations at the CDKN2A (p16/MTS1) locus in soft tissue tumors.Semantic proximity Read ↗

Frequent alterations in p16/CDKN2A identified by immunohistochemistry and FISH in chordomaSemantic proximity Read ↗

No p16INK4A/CDKN2/MTS1 mutations independent of p53 status in soft tissue sarcomas.Semantic proximity Read ↗

Aberrant expression of cell-cycle regulatory proteins in human mesenchymal neoplasia.Semantic proximity Read ↗

Overexpression of p53 and rare genetic mutation in mesenchymal chondrosarcoma.Semantic proximity Read ↗

Infrequent mutation of the p16/MTS1 gene and overexpression of cyclin-dependent kinase 4 in human primary soft-tissue sarcoma.Semantic proximity Read ↗

Molecular analysis of the INK4A/INK4A‐ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progressionSemantic proximity Read ↗

Infrequent CDKN2 (MTS1/p16) gene alterations in human primary breast cancer.Semantic proximity Read ↗

Decreased expression of the p16/MTS1 gene without mutation is frequent in human urinary bladder carcinomas.Semantic proximity Read ↗

Infrequent mutations and no methylation of CDKN2A (P16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.